U.S. Physical Therapy, Inc. $USPH Stock: William Blair Investment Management LLC Increases Holdings

Key Points

• William Blair Investment Management increased its U.S. Physical Therapy stake by 50.9% in the third quarter, adding 222,513 shares to bring its holding to 659,509 shares, worth about $56.5 million.
• The company beat quarterly estimates, reporting $0.80 in earnings per share and $222.56 million in revenue; revenue rose 12.9% year over year.
• Analysts give USPH a consensus “Moderate Buy” rating and a $104.25 average price target. The company also declared a quarterly dividend of $0.46 per share, equivalent to a 1.8% annualized yield.

William Blair Investment Management LLC grew its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 50.9% in the third quarter, according to its most recent filing with the SEC. The fund owned 659,509 shares of the company's stock after acquiring an additional 222,513 shares during the period. William Blair Investment Management LLC owned 4.42% of U.S. Physical Therapy worth $56,540,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of USPH. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in U.S. Physical Therapy during the 2nd quarter worth $30,000. Allworth Financial LP raised its position in U.S. Physical Therapy by 1,341.7% in the third quarter. Allworth Financial LP now owns 346 shares of the company's stock valued at $30,000 after purchasing an additional 322 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new stake in shares of U.S. Physical Therapy during the second quarter valued at about $33,000. Fulcrum Asset Management LLP acquired a new stake in shares of U.S. Physical Therapy during the third quarter valued at about $35,000. Finally, Sterling Capital Management LLC grew its holdings in shares of U.S. Physical Therapy by 221.0% during the third quarter. Sterling Capital Management LLC now owns 443 shares of the company's stock worth $38,000 after purchasing an additional 305 shares during the last quarter.

U.S. Physical Therapy Trading Up 0.9%

NYSE USPH traded up $0.87 during mid-day trading on Friday, reaching $99.47. 148,432 shares of the stock were exchanged, compared to its average volume of 191,591. U.S. Physical Therapy, Inc. has a one year low of $58.19 and a one year high of $101.80. The stock has a 50 day simple moving average of $86.32 and a 200-day simple moving average of $77.39. The stock has a market cap of $1.48 billion, a P/E ratio of -73.68, a P/E/G ratio of 2.71 and a beta of 1.16. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.42 and a quick ratio of 1.42.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.76 by $0.04. The firm had revenue of $222.56 million during the quarter, compared to the consensus estimate of $214.48 million. U.S. Physical Therapy had a return on equity of 10.19% and a net margin of 3.60%. The company's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.66 earnings per share. On average, analysts anticipate that U.S. Physical Therapy, Inc. will post 2.87 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 11th. Investors of record on Monday, November 16th will be given a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Monday, November 16th. U.S. Physical Therapy's dividend payout ratio is presently -136.30%.

Wall Street Analyst Weigh In

USPH has been the subject of several recent research reports. JPMorgan Chase & Co. upped their price objective on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an "overweight" rating in a research note on Friday, September 11th. Citigroup reissued a "market outperform" rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. Barrington Research upped their price target on U.S. Physical Therapy from $110.00 to $122.00 and gave the company an "outperform" rating in a research report on Friday. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $104.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics across the United States. Its clinics provide rehabilitation for musculoskeletal conditions, orthopedic injuries, sports-related injuries and recovery following surgery, along with other therapy services tailored to patients' needs. Founded in 1990 and headquartered in Houston, Texas, the company also provides industrial injury prevention and related services to employers. Its clinic network serves communities in multiple states, with care delivered through local therapy practices.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.